Consultant for this discipline
Gregory Sivo
Founder · Practising GMP quality professional
- · Founder, Truex Consultancy: GMP and GDP compliance
- · 10+ years in regulated pharmaceutical quality
- · Personally conducts every technical conversation
0 vacancies
Interim Quality Leadership jobs in Groningen at pharma, biotech and CDMO sites, technically screened by a GMP consultant. There are currently 0 open roles in Groningen and the surrounding area. Interim QA Managers, Heads of Quality, Quality Directors and remediation leads who can take over a quality organisation on Monday and hold an inspection on Friday. GMP jobs in Groningen: biologics CDMOs, API manufacturing in the north and university biotech spin-outs, a growing market with the lowest cost of living of any Dutch pharma cluster. Salaries for Interim Quality Leadership roles run from €75–110k gross per year across medior to senior profiles; interim day rates and regional differences are in our salary guide. Every vacancy states the client type, contract form, salary band and whether Dutch is required. Not seeing the right role? Register and we will call you when one opens; most Interim Quality Leadership roles in this market are never advertised.
No vacancies match these filters. Register and we will call you when one opens.
Register / upload CVConsultant for this discipline
Founder · Practising GMP quality professional
It depends on who is available and on the notice they carry. We say on the first call whether we have someone realistic for the timing, and we do not send a profile to fill the gap if we do not.
Freelance contracting suits established independents on shorter assignments. Secondment through Pharma Recruit suits longer assignments and sites that want the employment and contracting obligations on our side. We advise per case, and the terms are agreed in writing before the start.
Sometimes, and it is discussed at the start rather than at the end. Many interim leaders prefer to stay project-based; where a conversion is realistic, the terms are in the agreement.
Biologics CDMOs, university biotech spin-outs, hospital GMP units and API manufacturers in the Delfzijl–Emmen corridor.
Usually yes, the local pool is small, so relocation support and the 30 % ruling are standard for internationals.